References
- Directive 192004/27/EC of the European Parliament and of the Council of 31st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 136/34–57
- European Generic Medicines Association. Basic notions of generics. Brussels: European Generic Medicines Association, 2007. Available at: www.egagenerics.com [Last accessed 26 March 2007]
- European Commission. Innovation in the pharmaceutical sector. Brussels: Charles River Associates, 2004. Available at: pharmacos.eudra.org [Last accessed 12 March 2007]
- Karwal V. The changing competitive landscape in the global generics market: threat or opportunity? J Generic Medicines 2006;3:269–79
- Perry G. The European generic pharmaceutical market in review: 2006 and beyond. J Generic Medicines 2006;4:4–14
- Simoens S, Decoster S. Sustaining generic medicines markets in Europe. Leuven: Katholieke Universiteit Leuven, 2006. Available at: www.egagenerics.com [Last accessed 8 March 2007]
- Schulz A. Evolving dynamics of US and European generics markets. J Generic Medicines 2004;2:23–32
- IMS Health. MIDAS database. Brussels: IMS Health, 2006
- Patented Medicine Prices Review Board. A study of the prices of the top selling multiple source medicines in Canada. Ottawa: Patented Medicine Prices Review Board, 2002
- Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin 2007;23: 105–16
- Patented Medicine Prices Review Board. Non-patented prescription drug prices reporting. Canadian and foreign price trends. Ottawa: Patented Medicine Prices Review Board, 2006
- Tafuri G, Creese A, Reggi V. National and international differences in the prices of branded and unbranded medicines. J Generic Medicines 2004;1:120–7
- Danzon P, Chao L. Cross-national price differences for pharma ceuticals: how large, and why? J Health Econ 2000; 19:159–95